Population-level health and economic impacts of introducing Vaccae vaccination in China: a modelling study
Introduction Given the ageing epidemic of tuberculosis (TB), China is facing an unprecedented opportunity provided by the first clinically approved next-generation TB vaccine Vaccae, which demonstrated 54.7% efficacy for preventing reactivation from latent infection in a phase III trial. We aim to a...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-05-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/8/5/e012306.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|